SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001561743-16-000076
Filing Date
2016-11-07
Accepted
2016-11-07 16:07:26
Documents
47
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q kindred10qq32016.htm 10-Q 617592
2 EXHIBIT 31.1 exhibit311q32016.htm EX-31.1 13288
3 EXHIBIT 32.1 exhibit321q32016.htm EX-32.1 6858
  Complete submission text file 0001561743-16-000076.txt   3520761

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT kin-20160930.xml EX-101.INS 818684
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT kin-20160930.xsd EX-101.SCH 24479
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT kin-20160930_cal.xml EX-101.CAL 45391
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT kin-20160930_def.xml EX-101.DEF 113799
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT kin-20160930_lab.xml EX-101.LAB 329217
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT kin-20160930_pre.xml EX-101.PRE 192602
Mailing Address 1555 BAYSHORE HIGHWAY, SUITE 200 BURLINGAME CA 94010
Business Address 1555 BAYSHORE HIGHWAY, SUITE 200 BURLINGAME CA 94010 650-701-7901
Kindred Biosciences, Inc. (Filer) CIK: 0001561743 (see all company filings)

IRS No.: 461160142 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36225 | Film No.: 161978151
SIC: 2834 Pharmaceutical Preparations